• About Us
    • Fact Checking Policy
    • Ownership & funding information
  • Volunteer
    • Internship with The Online Citizen
  • Donation
  • Subscription
  • Letter submission
    • Submissions Policy
  • Contact Us
The Online Citizen Asia
  • Opinion
    • Editorial
    • Commentaries
    • Comments
  • Current Affairs
    • Malaysia
    • Indonesia
    • China
    • ASEAN
    • Asia
    • International
  • Finance
    • Economics
    • Labour
    • Property
    • Business
  • Community
    • Civil Society
    • Arts & Culture
    • Consumer Watch
    • NGO
  • Politics
    • Parliament
    • Transport
    • Education
    • Environment
    • Health
    • Housing
  • Law & Order
    • Legislation
    • Court Cases
  • Lifestyle
    • Travel
No Result
View All Result
  • Opinion
    • Editorial
    • Commentaries
    • Comments
  • Current Affairs
    • Malaysia
    • Indonesia
    • China
    • ASEAN
    • Asia
    • International
  • Finance
    • Economics
    • Labour
    • Property
    • Business
  • Community
    • Civil Society
    • Arts & Culture
    • Consumer Watch
    • NGO
  • Politics
    • Parliament
    • Transport
    • Education
    • Environment
    • Health
    • Housing
  • Law & Order
    • Legislation
    • Court Cases
  • Lifestyle
    • Travel
No Result
View All Result
The Online Citizen Asia
No Result
View All Result

Russia says Sputnik V virus vaccine 92% effective

by The Online Citizen
11/11/2020
in Health, International
Reading Time: 2 mins read
6

TOMSK, RUSSIA - October 6, 2020: A medical worker vaccinates a volunteer with the Russian Sputnik-V COVID-19 vaccine at hospital during the pandemic.

Russia’s Sputnik V coronavirus vaccine is 92 percent effective according to initial test results, its developers said on Wednesday, as Moscow races against its competitors in the West.

The calculations were based on results from 16,000 individuals who received both doses of the vaccine, Russia’s health ministry, the state-run Gamaleya research centre and the Russian Direct Investment Fund (RDIF) said in a statement.

“The Sputnik V vaccine had an efficacy rate of 92 percent after the second dose,” the statement said, after 20 of the volunteers — some of whom were given the placebo — tested positive for coronavirus.

The adenovirus vector-based vaccine uses modified viruses of the regular flu.

Some of those vaccinated experienced “pain at the injection site, flu-like syndrome including fever, weakness, fatigue and headache,” the statement said.

Russia in August became the first country to register a coronavirus vaccine but did so ahead of the large-scale clinical trials that are still underway.

Forty thousand volunteers at 29 medical centres are taking part in the third and final phase of Sputnik V trials.

In September, the vaccine was separately administered to medics and other at-risk people working in Russian hospitals, demonstrating an efficacy rate of “over 90 percent,” the statement said.

Regional authorities in Siberia’s Altai region on Tuesday said that at least three medics out of the 42 that received the vaccine had contracted the virus.

Wednesday’s statement added that the interim research data will be published in one of the world’s “leading peer-reviewed medical academic journals”.

Observation of trial participants will continue for six months, after which the full clinical trial report will be presented, it added.

The statement said that RDIF, which is funding development of Sputnik V, will provide research data to countries that are interested in purchasing the Russian vaccine.

Overseas trials are also taking place in the UAE, Venezuela, Belarus and other countries, the statement said.

The announcement of Sputnik V’s interim results comes days after Western vaccine developers Pfizer and BioNTech said that their vaccine was more than 90 percent effective.

– AFP

Share this:

  • Twitter
  • Facebook
Source: AFP
Tags: AFPCOVID-19
Subscribe
Connect withD
Login
I allow to create an account
When you login first time using a Social Login button, we collect your account public profile information shared by Social Login provider, based on your privacy settings. We also get your email address to automatically create an account for you in our website. Once your account is created, you'll be logged-in to this account.
DisagreeAgree
Notify of
I allow to create an account
When you login first time using a Social Login button, we collect your account public profile information shared by Social Login provider, based on your privacy settings. We also get your email address to automatically create an account for you in our website. Once your account is created, you'll be logged-in to this account.
DisagreeAgree
6 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments

Recent Posts

  • Only 1 in 5 surveyed confident of 4G leaders, Blackdot Research study finds
  • Taiwan truck driver charged with negligent homicide over rail crash
  • Myanmar’s ousted MPs form shadow government
  • France says ‘highly probable’ EU won’t renew AstraZeneca orders
  • Jimmy Lai: the Hong Kong media tycoon that China loathes
  • Jimmy Lai among five Hong Kong democracy activists jailed
  • Rebel groups see opportunity in post-coup Myanmar
  • Public Prosecutors have nothing to fear if they do their job, says Justice Chan Seng Onn as Parti Liyani becomes first to seek compensation against AGC for “frivolous and vexatious” prosecution

Trending posts

Only 1 in 5 surveyed confident of 4G leaders, Blackdot Research study finds

Ho Ching shares not 1, not 2, but 7 Facebook posts by Chan Chun Sing in a row within 15 minutes

HDB steps up to assist single mom after her social media post on being given unliveable flat goes viral

WP MP Gerald Giam’s intervention helped solve traffic congestion issue at Hougang Capeview

Blogger Roy Ngerng hits fundraising target in 8 days for damages to be paid to PM Lee over libel suit

PM Lee seeking nearly S$130,000 in legal costs and disbursements from blogger Leong Sze Hian; much of disbursements tied to engagement of Hong Kong expert witness

Only 1 in 5 surveyed confident of 4G leaders, Blackdot Research study finds

Public Prosecutors have nothing to fear if they do their job, says Justice Chan Seng Onn as Parti Liyani becomes first to seek compensation against AGC for “frivolous and vexatious” prosecution

Here’s why many Singaporeans aren’t bothered who the ruling party chooses to become PM

Pfizer CEO: Vaccine third dose ‘likely’ needed within 12 months

Load More
November 2020
MTWTFSS
 1
2345678
9101112131415
16171819202122
23242526272829
30 
« Oct   Dec »
  • About Us
  • Volunteer
  • Donation
  • Subscription
  • Letter submission
  • Contact Us

© 2006 - 2021 The Online Citizen

No Result
View All Result
  • Opinion
    • Editorial
    • Commentaries
    • Comments
  • Current Affairs
    • Malaysia
    • Indonesia
    • China
    • ASEAN
    • Asia
    • International
  • Finance
    • Economics
    • Labour
    • Property
    • Business
  • Community
    • Civil Society
    • Arts & Culture
    • Consumer Watch
    • NGO
  • Politics
    • Parliament
    • Transport
    • Education
    • Environment
    • Health
    • Housing
  • Law & Order
    • Legislation
    • Court Cases
  • Lifestyle
    • Travel
  • Subscribers login

© 2006 - 2021 The Online Citizen

wpDiscuz
6
0
Would love your thoughts, please comment.x
()
x
| Reply